Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251317 | SCV000302089 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Laboratory for Molecular Medicine, |
RCV000251317 | SCV000711885 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | c.933+14T>C in intron 16 of COL4A3: This variant is not expected to have clinica l significance because it is not located within the splice consensus sequence an d has been identified in 3.58% (2388/66624) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs55928538) . |
Illumina Laboratory Services, |
RCV001143136 | SCV001303638 | benign | Alport syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Labcorp Genetics |
RCV001513059 | SCV001720592 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001527203 | SCV001738149 | benign | Autosomal recessive Alport syndrome | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001513059 | SCV001802194 | likely benign | not provided | 2018-07-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001513059 | SCV005259014 | likely benign | not provided | criteria provided, single submitter | not provided |